APP and Alzheimer disease: The effects of Hp-OMVs on brain functions and AD pathology have recently been studied in wild-type (WT) mice and AppNL-G-F AD mice, a second-generation mouse model of AD in which, unlike most other transgenic mouse models, the mutant amyloid precursor protein (APP) is not overexpressed, thereby avoiding potential artifacts [262].